Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2026-05-23 @ 7:49 AM
Study NCT ID:
NCT01026727
Status:
TERMINATED
Last Update Posted:
2010-06-14
First Post:
2009-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Sponsor:
Myrexis Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MPC-4326-003.01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Andrew Beelen, MD
Old Organization:
Myriad Pharmaceuticals, Inc